跳至主要内容
临床试验/NCT06031753
NCT06031753已完成不适用

Time-restricted Eating as a Novel Approach to PCOS Remission, Compared to Guideline's Standard Hormonal Treatment.

Instituto Superior de Investigación en Estética Médica, Nutrición y Anti-Envejecimiento2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2021年6月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
16
试验地点
2
主要终点
PCOS Rotterdam criteria

研究概览

简要总结

The purpose of this study is to assess the effects of Time restricted eating in patients diagnosed with polycystic ovary syndrome, comparing it to the standard hormonal treatment.

详细描述

After being informed about the study and potential risks, all patients were given a written informed consent. Patients were recruited through social media and digital questionnaires, to make sure they met the criteria. There was a semi aleatory distribution of the patients into three different groups, one group underwent time restricted eating with no hormonal treatment (TRE group), the second group received hormonal treatment combined with time restricted eating (combined group) and the last group received only hormonal treatment (HT). PCOS was diagnosed using Rotterdam criteria, which were evaluated according to the ultrasound, blood samples and self reported menstrual cycle.

Blood samples and transvaginal ultrasound were taken at day 0 and 90 to evaluate hormonal status, including insulin and glucose.

Homeostatic assessment for insulin resistance (HOMA-IR) was calculated to determine insulin resistance, as well as metabolic disfunction.

After data collection, statistical analyses was done to determine the effect of the different approaches.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Age: 20 - 35 years
  • Mild to moderate exercise at least 4 times per week
  • Body Mass Index (BMI) of 20-24.9
  • Diagnosis of PCOS by Rotterdam criteria
  • Type of oral contraceptives: combined (estrogens and progestins) in group 1 and
  • PCOS Phenotype A, B, C
  • nulliparity
  • Signed informed consent letter

排除标准

  • Menopause or perimenopause
  • Night work shifts
  • Phenotype D (without hyperandrogenism)
  • Associated pathologies such as diabetes mellitus, arterial hypertension, metabolic syndrome, neoplasms, autoimmune diseases.
  • Intake of medications on a regular basis, not including oral contraceptives for group 1 and 2.

结局指标

主要结局

PCOS Rotterdam criteria

时间窗: 3 months

Ovary volume \>9ml, presence of 12 or more follicles, biochemical or clinical signs of hyperandrogenism and anovulation.

次要结局

  • Insulin resistance (IR)(3 months)

研究者

发起方
Instituto Superior de Investigación en Estética Médica, Nutrición y Anti-Envejecimiento
申办方类型
Other
责任方
Principal Investigator
主要研究者

Isabela von Damm Longoria

Principal investigator

Instituto Superior de Investigación en Estética Médica, Nutrición y Anti-Envejecimiento

研究点 (2)

Loading locations...

相似试验